Study of XL999 in Patients With Metastatic Colorectal Cancer
NCT00277303
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was terminated due to cardiac toxicities in the subjects
Conditions
Colorectal Cancer
Interventions
DRUG:
XL999
Sponsor
Symphony Evolution, Inc.